Across TCGA pan-cancer cohorts, GOLGA8G Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated GOLGA8G data layer compared with 19 for mass-spec protein.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher GOLGA8G Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated GOLGA8G expression acts as an unfavorable survival marker.

LUSC and CESC are the cancer types where GOLGA8G Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Median	All	0.011	0.819	<.001	12	view →
CESC	DFS	Median	All	0.174	0.740	.004	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: GOLGA8G tumor-vs-normal RNA expression · all GOLGA8G data types